Stockwinners Market Radar for January 20, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:50 EST Processa Pharmaceuticals Inc trading halted, news pending

19:50 EST Nuvve Holding Corp trading halted, news pending

17:02 EST JetBlue, Spirit Airlines file notice of appeal for ruling blocking merger - JetBlue (JBLU) and Spirit Airlines (SAVE) reported that they have jointly filed a notice of appeal to the U.S. Court of Appeals for the First Circuit, consistent with the requirements of the merger agreement.

17:01 EST Microsoft says threat actor accessed employee, executive email accounts - Microsoft said in a regulatory filing that, on January 12, 2024, it detected that beginning in late November 2023, a nation-state associated threat actor had gained access to and exfiltrated information from a very small percentage of employee email accounts including members of its senior leadership team and employees in its cybersecurity, legal, and other functions, on the basis of preliminary analysis. "We were able to remove the threat actor's access to the email accounts on or about January 13, 2024," the company said. "We are examining the information accessed to determine the impact of the incident. We also continue to investigate the extent of the incident. We have notified and are working with law enforcement. We are also notifying relevant regulatory authorities with respect to unauthorized access to personal information. As of the date of this filing, the incident has not had a material impact on the Company's operations. The Company has not yet determined whether the incident is reasonably likely to materially impact the Company's financial condition or results of operations."

16:21 EST Nuvini receives Nasdaq notice of deficiency - Nuvini announced that it received a notice of deficiency from the Nasdaq Stock Market. The deficiency cited by Nasdaq in the Notice is the result of the previously-announced resignation of Mr. Randy Millian from the board of directors of the company and the audit committee of the Board. With the resignation of Mr. Millian, the company is currently not in compliance with Nasdaq Listing Rule 5605(c)(2)(A) requiring three independent members on its audit committee.

16:06 EST First Solar acquires 1.2M square foot facility in Ohio - First Solar announced that it has acquired a 1.2M square foot facility in Troy Township, Ohio. The facility, formerly known as Peloton Output Park, is expected to be repurposed into a new distribution center serving First Solar's Ohio manufacturing footprint, which comprises three manufacturing facilities with a combined annual nameplate capacity of approximately 6 gigawatts of capacity at the end of 2023. In addition to expanding its Ohio footprint to over 7 GW of annual nameplate capacity this year, the solar technology and manufacturing company expects to invest over $2B in new manufacturing facilities in Alabama and Louisiana. First Solar expects to have 14 gigawatts of fully vertically integrated US solar manufacturing capacity by 2026. Additionally, First Solar is investing up to $370M in a dedicated R&D innovation center in Perrysburg, Ohio, which is expected to be completed in 2024.

15:58 EST Vanda Pharmaceuticals says court denied in part U.S. motion to dismiss - Vanda Pharmaceuticals announced that the United States Court of Federal Claims in Washington, D.C. denied in part the government's motion to dismiss Vanda's claim against the United States for the Food and Drug Administration's "uncompensated taking of Vanda's trade secrets and confidential information." Vanda is seeking compensation from the United States "for the takings it contends occurred through the FDA's improper communication and disclosure of trade secrets and confidential information to certain generic drug manufacturers." Vanda filed the lawsuit on May 1, 2023, and the United States moved to dismiss. On January 8, the court held an oral argument on the government's motion. On January 18, the court denied the government's motion in part, allowing Vanda's takings claim to move forward. Vanda now intends to engage in discovery to support its claims.

15:27 EST OPDP says Novartis' Kisqali TV ad makes false or misleading representations - The Office of Prescription Drug Promotion of the U.S. Food and Drug Administration said in a letter that it has reviewed the promotional communication, a direct-to-consumer broadcast advertisement, "KISQALI_MBC_Long Live-Post Meno_US_11.22" for KISQALI tablets, for oral use submitted by Novartis Pharmaceuticals Corporation under cover of Form FDA 2253. The TV ad makes false or misleading representations about the efficacy of Kisqali. Thus, the TV ad misbrands Kisqali within the meaning of the Federal Food, Drug and Cosmetic Act (FD&C Act) and makes its distribution violative. 21 U.S.C. 352 (n); 321(n); 331(a). 21 CFR 202.1(e)(5). This violation is particularly concerning because the overstated representations about Kisqali's efficacy could lead patients with advanced or metastatic breast cancer, an incurable condition whose treatment involves serious risks, to believe that Kisqali has been shown to be more effective in treating their condition and symptoms (e.g., with respect to overall survival and quality of life) than was actually demonstrated. Breast cancer is a serious public health concern in the United States with 297,790 new cases and 43,170 deaths estimated in 2023 in female patients. Reference Link

14:59 EST Prime Medicine treatment of chronic granulomatous disease granted orphan status - Prime Medicine's treatment of chronic granulomatous disease was granted orphan status by the FDA, according to a post to the agency's website. Reference Link

14:51 EST StoneBridge Acquisition Corp trading resumes

14:46 EST StoneBridge Acquisition Corp trading halted, volatility trading pause

13:34 EST Universal Electronics says court backs Roku infringing products import ban - Universal Electronics (UEIC) announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. International Trade Commission, which banned the importation and sale of various streaming products by Roku (ROKU) that infringe UEI's patent. The appellate court's ruling issued today. "We are pleased that the Federal Circuit has validated our valuable intellectual property and confirmed Roku's patent infringement. It further confirms that Roku will not be able to import or sell any infringing products in United States until this key UEI patent expires in 2032. Our U.S. District Court cases against Roku and its TV partners were on hold until this decision was finalized, so this decision now paves the way for UEI to return to the U.S. District Court and collect money damages for the infringing activities of Roku and its TV partners," said Richard Firehammer, Jr. UEI's SVP & General Counsel.

13:16 EST Arena Group says ABG to terminate Sports Illustrated licensing agreement - In a regulatory filing, Arena Group stated: "As previously reported, on January 2, 2024, The Arena Group Holdings, Inc. failed to make a quarterly payment due to ABG-SI LLC, pursuant to the Licensing Agreement, dated June 14, 2019, by and between the company and ABG, of approximately $3,750,000. On January 18, 2024, ABG notified the company of its intention to terminate the Licensing Agreement, effective immediately, in accordance with its rights under the Licensing Agreement. Upon such termination, a fee of $45M became immediately due and payable by the company to ABG pursuant to the terms and conditions of the Licensing Agreement. In addition, upon termination of the Licensing Agreement, any outstanding and unvested warrants to purchase shares of the company's common stock issued to ABG in connection with the Licensing Agreement became immediately vested and exercisable. The company is engaging in continuing discussions with ABG regarding the Licensing Agreement. The Licensing Agreement previously provided the company with the exclusive right and license in the United States, Canada, Mexico, United Kingdom, Republic of Ireland, Australia, and New Zealand to operate the Sports Illustrated media business in the English and Spanish languages, including to (i) operate the digital and print editions of Sports Illustrated, including all special interest issues and the swimsuit issue, and Sports Illustrated for Kids, (ii) develop new digital media channels under the Sports Illustrated brands, and (iii) operate certain related businesses, including without limitation, certain Sports Illustrated events, special interest publications, video channels, bookazines, and the licensing and/or syndication of certain products and content under the Sports Illustrated brand. The initial term of the Licensing Agreement extended through December 31, 2029, subject to each party's termination rights. The company had the option, subject to certain conditions, to renew the term of the Licensing Agreement for nine consecutive renewal terms of 10 years each, for a total of 100 years. The Licensing Agreement provided that the company would pay to ABG annual royalties in respect of each year of the Term based on gross revenues with guaranteed minimum annual amounts. ABG agreed to pay to the company a share of revenues relating to certain Sports Illustrated business lines not licensed to the company, such as commerce."

13:09 EST Spire completes acquisition of MoGas, Omega pipeline systems from CorEnergy - Spire Inc. (SR) announced it has completed its acquisition of MoGas Pipeline, an interstate natural gas pipeline, and Omega Pipeline, a connected gas distribution system, from CorEnergy (CORR). The acquisition was completed for $175M, subject to customary closing adjustments. The businesses will join Spire's existing midstream infrastructure, including Spire Storage and Spire STL Pipeline. As a result of the acquisition, MoGas will operate under the new legal name Spire MoGas Pipeline LLC. "Spire MoGas and Omega are ideal fits with our existing businesses and will further enhance our ability to serve customers in Missouri," said Steve Lindsey, Spire president and CEO.

13:02 EST Baker Hughes reports U.S. rig count up 1 to 620 rigs - Baker Hughes reports that the U.S. rig count is up 1 from last week to 620 with oil rigs down 2 to 497, gas rigs up 3 to 120 and miscellaneous rigs unchanged at 3. The U.S. Rig Count is down 151 rigs from last year's count of 771 with oil rigs down 116, gas rigs down 36 and miscellaneous up 1 to 2. The U.S. Offshore Rig Count is unchanged at 20, up 4 year-over-year. The Canada Rig Count is up 10 from last week to 223, with oil rigs up 7 to 140, and gas rigs up 3 to 83. The Canada Rig Count is down 18 from last year's count of 241, with oil rigs down 13, and gas rigs down 5.

12:54 EST Arena Grp trading halted, news pending

12:31 EST Bank of the James increases quarterly dividend 25% to 10c per share - On January 16, 2024, the Board of Directors of Bank of the James Financial Group declared a cash dividend in the amount of 10c per common share. This is an increase of 2c per common share, or 25%, from the dividend declared in October 2023. The dividend is payable on March 15, 2024 to shareholders of record at the close of business on March 1, 2024.

12:00 EST Lithium Argentina falls -11.3% - Lithium Argentina is down -11.3%, or -56c to $4.46.

12:00 EST Spirit Airlines rises 23.3% - Spirit Airlines is up 23.3%, or $1.33 to $7.03.

12:00 EST Kaman rises 101.3% - Kaman is up 101.3%, or $22.71 to $45.15.

11:50 EST Wynnefield Capital sends letter to TechPrecision's board of directors - Wynnefield Capital and its affiliates, collectively the largest institutional stockholder of TechPrecision Corporation, with a 4.5% beneficial ownership interest, issued a public letter to the company's Board of Directors. The letter says in part: "In its first public letter on December 7, 2023, Wynnefield asked the company to hold a public conference call to explain the proposed acquisition of Votaw Precision Technologies. After receiving no response to this very reasonable request, on December 19, 2023, we publicly questioned why the board was unwilling to disclose the transaction's funding strategy. TechPrecision has given just a generalized response with no material details. Wynnefield remains alarmed by this Board of Directors' disregard for its duties to ALL stockholders, the uncertainty it has created and its contribution to stockholder value destruction. TechPrecision's board has not earned stockholder trust to approve at its sole discretion, under any circumstance, the proposed Votaw transaction. The claim "the board is unanimous in support of the acquisition" should not be reason to circumvent stockholder interests to weigh in and vote on a proposed transformational acquisition. Just when unfavorable voting results were reported following the September 12, 2023, annual meeting of stockholders, the board was approving the execution of a letter of intent with Votaw knowing that the potential acquisition could cause significant dilution to existing TechPrecision stockholders. Wynnefield is at a total loss why the company would not engage immediately with its shareholders. We intend to carefully monitor the inevitable dilutive capital raise to ensure equal access opportunity for all shareholders. Wynnefield has operated for over 30 years and never witnessed anything quite this bizarre. Wynnefield Capital demands accountability given the destruction of stockholder capital. It is time this board and management ADMIT their shortcomings and publicly ENGAGE with stockholders... TechPrecision stockholders have been patient investors, but recent board actions have been devastating. While Votaw's valuation incorporates just recently improved financial performance, existing TechPrecision stockholders would give up full ownership of RANOR and STADCO just months before their production ramps up and after waiting patiently for years."

11:33 EST Alvotech says FDA reinspection of facility in Iceland concluded - Alvotech announced that the reinspection of Alvotech's facility in Iceland by the U.S. Food and Drug Administration, which started on January 10, has been concluded. "Following the FDA inspection, Alvotech received a form 483 with one observation. Alvotech expects to provide the FDA with a response in the following days. Based on the conclusion of the facility reinspection, Alvotech believes it is in a position to receive approval in the U.S. for AVT02 and AVT04 by February 24, 2024, and April 16, 2024, their respective goal dates," the company stated. "We believe that the observation is readily addressable, and we intend to respond as quickly as possible," said Robert Wessman, Chairman and CEO of Alvotech.

10:50 EST ChargePoint among first companies to receive FedRAMP approval, says GSA - The U.S. General Services Administration on Friday announced that GSA has finalized authorizations for the first two electric vehicle supply equipment vendors, Chargie and ChargePoint, to operate inside government systems. This will allow them to become FedRAMP authorized, which gives assurance to federal agency partners that electric vehicle charging stations have their security measures fully vetted and authorized through the agency's blanket purchase agreement, the GSA said in a statement, adding that these actions will help accelerate the nation's clean transportation future through President Biden's Investing in America agenda. In addition, GSA is working to authorize six more EVSE vendors later this year. "This is a big deal for both the EVSE industry as well as our federal partners purchasing charging stations," said Administrator Carnahan. "Our customers have an extra level of assurance now that these companies will receive FedRAMP authorization. It's a win for small businesses and for expanding our country's vehicle electrification infrastructure." Reference Link

10:20 EST Delta to cancel Tel Aviv flights through April 30 - Delta said in an update on its news hub that it is continuously monitoring the security situation in Tel Aviv and updating its service between Ben Gurion Airport - TLV - and New York, Atlanta and Boston on an ongoing basis. Delta in October suspended booking for TLV flights to and from Hartsfield-Jackson Atlanta International Airport - ATL - and Boston Logan International Airport - BOS; those services remain suspended. Delta flights between TLV and New York's John F. Kennedy International Airport - JFK - will continue to be canceled until April 30, 2024. Sales of these flights are suspended. Reference Link

10:06 EST AstraZeneca says Imfinzi combo improved survival in carcinoma patients - AstraZeneca says positive results from the EMERALD-1 Phase III trial showed Imfinzi in combination with TACE and bevacizumab demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of progression-free survival compared to TACE alone in patients with hepatocellular carcinoma eligible for embolisation. In EMERALD-1, treatment with Imfinzi plus TACE and bevacizumab reduced the risk of disease progression or death by 23% compared to TACE alone. Median PFS was 15 months in patients treated with the Imfinzi combination versus 8.2 months with TACE. The PFS benefit observed was generally consistent across key prespecified subgroups, according to the company. The secondary endpoint of time to progression further supports the clinical benefit of Imfinzi plus TACE and bevacizumab in this setting, with a median TTP of 22 months versus 10 months for TACE, it added. The trial will continue as planned to assess the key secondary endpoint of overall survival. Reference Link

10:01 EST Huntington Ingalls unit awarded $197M contract - HII announced that its Mission Technologies division was awarded a $197M recompete task order contract to conduct research and development for the Joint Training Synthetic Environment, which blends live and virtual training into a single synthetic environment that enables joint force readiness. Administered by the Joint Staff J7, Deputy Director of Joint Training, HII will develop, maintain, support and provide joint training in a synthetic environment across combatant commands, military service branches, federal agencies, academia, industry and multi-national partners. The JTSE is designed to evolve with changing operational needs, providing accessible exercises that mirror the complexity of real-world scenarios.

10:00 EST Lifezone Metals falls -10.1% - Lifezone Metals is down -10.1%, or -71c to $6.31.

10:00 EST Spirit Airlines rises 16.3% - Spirit Airlines is up 16.3%, or 93c to $6.63.

10:00 EST Kaman rises 101.1% - Kaman is up 101.1%, or $22.68 to $45.11.

09:55 EST FDA adds boxed warning to Amgen's Prolia - The Food and Drug Administration announced that it added a boxed warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia. The drug is made by Amgen. Reference Link

09:52 EST FDA adds boxed warning to Amgen's Prolia - The Food and Drug Administration announced that it added a boxed barning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia. The drug is made by Amgen. Reference Link

09:47 EST Chegg falls -10.5% - Chegg is down -10.5%, or -$1.05 to $9.01.

09:47 EST Spirit Airlines rises 23.2% - Spirit Airlines is up 23.2%, or $1.32 to $7.03.

09:47 EST Kaman rises 101.2% - Kaman is up 101.2%, or $22.69 to $45.12.

09:40 EST CCSC Technology International Hldngs Ltd trading halted, volatility trading pause

09:30 EST SciSparc enters into bridge loan agreement with vehicle importer in Israel - SciSparc entered, as lender, into a bridge loan agreement with a vehicle importer company in Israel, as borrower, pursuant to which the Target Company received a bridge loan in the amount of $1.4 million, further to the previously-announced non-binding letter of intent for the Company to acquire the Target Company. With this Bridge Loan, SciSparc continues to proceed towards the Acquisition, pursuant to the LOI and the additional negotiated terms between the Company and the Target Company, announced on November 22 and December 7, 2023, respectively. As previously announced on December 7, 2023, the Company intends to acquire 100% of the Target Company and will establish a new wholly-owned Israeli subsidiary, which would in turn merge with and into the Target Company. Following the Acquisition closing, it is contemplated that shareholders of the Company will hold approximately 50.01% of the share capital of the resulting combined company. The Agreement, signed on January 16, 2024, states that the principal amount of the Bridge Loan will bear interest at a rate of 7% per annum, compounded annually. The Bridge Loan amount, together with any accrued interest, may be repaid in part or in whole at the discretion of the Target Company prior to the repayment date. The repayment of the Owed Amount will be due at the earlier date of: the Closing, in which the Owed Amount shall be deemed a part of, and set-off against, the financing amount the Company will provide the Target Company with upon Closing, which is expected to be $4,250,000; or if the definitive agreement for the Acquisition is terminated in accordance with its terms, within three months from such termination date; or July 15, 2024

09:17 EST Bravo Multinational signs LOI to acquire Streaming TVEE assets - On December 20, 2023, Bravo Multinational entered a Letter of Intent to acquire certain assets of Streaming TVEE. The purchase price for the assets is $9,760,000, consisting of a convertible promissory note in the amount of $7,760,000 and an assumption of $2,000,000 in STV debt. The promissory note is convertible into the common stock of BRVO based on the December 11, 2023, closing price of BRVO common stock as traded or the OTC Market which is $0.15625. The LOI is subject to normal terms of an agreement of that nature. This transaction, if consummated, will serve as a business foundation for the Company's planned development of a streaming service called TVee NOW. The assets to be acquired will provide BRVO with the technology and music library streaming rights to offer content such as linear TV, often referred to as traditional broadcast TV, as well as an array of on-demand content, including but not limited to, movies, series, shows, concerts, comedy specials, events and more - all at no cost to its viewers. The parties have agreed to continue to move forward with the transaction by the preparation of a definitive agreement upon the completion of customary due diligence procedures.

09:11 EST Datasea hires U.S. marketing firm to promote intelligent acoustics products - Datasea's Delaware operating subsidiary, Datasea Acoustics, has entered into a marketing promotion and sales cooperation agreement with Meglio Interiors, based in Chamblee, Georgia, to develop, promote and distribute the company's intelligent acoustics products in the U.S. Datasea plans to establish an assembly line in the near future for its intelligent acoustics products in U.S, with Meglio serving as one of the primary distributors of such products. The agreement has an initial term of two years. Meglio has sales channels that include Atlanta, Dallas and New Jersey.

09:06 EST Global Industrial launches 'Open Space' initiative - Global Industrial Company announced the launch of its "Open Space" initiative at the U.S. Conference of Mayors' 92nd Winter Meeting in Washington, D.C. Open Space is an innovative concept created by Global Industrial to support the thoughtful configuration of public and private gathering spaces in an effort to promote communal well-being and mental health. During the conference, Barry Litwin, Chief Executive Officer of Global Industrial, participated in a fireside chat hosted by Mayor Hillary Schieve, President of the U.S. Conference of Mayors and Mayor of Reno, Nevada. Open Space by Global Industrial recognizes that the spaces we inhabit play an important role in the way we interact with others. Fostering a sense of community - whether it is in outdoor parks, hospitals, schools or work environments - can reinforce feelings of connectedness, and mitigate feelings of individual and collective isolation, and in so doing, enhance notions of social responsibility and productivity. The Open SpaceTM concept enables Global Industrial to customize an assortment of products to create environments for its customers that promote reflection and interpersonal exchange.

09:04 EST Ryvyl decides to retain subsidiary coyni - The Company decided to retain RYVYL's wholly owned subsidiary coyni, Inc. and use coyni technology platform to expand payment processing and banking-as-a-service solutions rather than pursue its merger and spin out into a new publicly traded entity. By maintaining a consolidated product roadmap, RYVYL expects to leverage coyni in both existing and targeted new vertical markets for better operating efficiencies and financial outcome.

08:48 EST Greenwave Technology adds operation of new equipment in Portsmouth facility - Greenwave Technology has commenced operation of a metal baler, wire stripper, and three sheers at its non-ferrous processing facility in Portsmouth, VA. The high capacity metal baler is capable of compacting large amounts of metal into dense bales, reducing the amount of labor and cost required to process, transport, and sell copper and aluminum products. By condensing more material into each load of metal it sells, the company will be able to reduce transportation costs and realize a greater profit margin. Greenwave recently completed its multi-year capex cycle, under which the company has invested more than $15M in its infrastructure and equipment over the past 24 months. This capex cycle is expected to double its ferrous metal processing capacity from fiscal 2022 levels and result in the Company having the infrastructure to accretively scale to over 20 metal recycling facilities.

08:45 EST Uber, AEG announce new long-term naming rights partnership - Uber and AEG have announced a new long-term partnership that sees the global brand take the naming rights for AEG's iconic two venues in Berlin-Friedrichshain, as well as the surrounding entertainment district. Effective March 22, the Uber Arena and Uber Eats Music Hall among the largest event locations in Berlin alongside the adjacent restaurants, cinema and bowling alley that make up Uber Platz, will be renamed in a deal in Germany, which sees Uber take naming rights for three of the company's most iconic assets across Europe. The new agreement was brokered by AEG Global Partnerships. Attracting 1.5 million visitors a year, the newly named Uber Arena, was recently ranked the second highest-grossing arena in the world, with the partnership chosen to mark 10 years of Uber's presence in Germany.

08:33 EST United Health Products to proceed with final drafting of PMA documentation - United Health Products reports on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze. As previously disclosed, UHP has been working with external packaging and sterilization service providers to complete various required tests for its Premarket Approval application. The reported data received this week on the efficacy of the proposed radiation sterilization protocol were well within acceptable bioburden levels for Class III products. UHP will now compile these data and proceed with final drafting of the PMA documentation to be submitted via the eSTAR platform for FDA and Health Canada review.

08:32 EST Safety Shot partners with SteveWillDoIt for Safety Shot promotion - Safety Shot announced that Steve Deleonardis of SteveWillDoIt, is partnering with the Company to promote Safety Shot, the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting mental clarity and mood. SteveWillDoIt has millions of followers and billions of views across YouTube, Instagram, TikTok, X, and Snapchat. As a social media influencer and content creator, Steve is known for his challenge videos, philanthropy, and high-profile collaborations with world-renown personalities. Safety Shot will be featured in SteveWillDoIt's lifestyle content across social media platforms, integrated into high-impact live events and collaborations with Steve's network of top influencers. Giveaways of the highly anticipated Safety Shot drink will be a key part of the promotions.

08:31 EST Vaxart receives $9.27M BARDA project award for Phase 2B trial on oral pill - Vaxart announced that the United States Biomedical Advanced Research and Development Authority, BARDA, has awarded the Company $9.27 million to fund preparation for a 10,000 subject Phase 2b clinical study evaluating Vaxart's oral pill XBB COVID-19 vaccine candidate against an approved mRNA vaccine comparator. "We are very honored to receive this BARDA award, which will support the innovative approach of our oral pill vaccine platform," said Dr. Michael Finney, Vaxart's Interim Chief Executive Officer. "We believe our oral pill vaccine platform may ultimately hold the promise of revolutionizing how we fight pandemics and how we vaccinate against several infectious diseases. Our team is very excited about this contract, which allows us to prepare to move forward with our oral COVID vaccine program, together with BARDA."

08:17 EST GDEV Inc. announces final results of self tender offer - GDEV announced the final results of the previously announced tender offer by the Company to purchase for cash a minimum of 15,000,000 of its ordinary shares, no par value per ordinary share up to a maximum of 20,000,000 shares, at a purchase price of $2.00 per share, net to the seller in cash, without interest, less any applicable withholding taxes, which expired at 5:00 p.m., Eastern Time, on January 18, 2024. Based on the final count by Continental Stock Transfer & Trust Company, the depositary for the tender offer 16,554,256 shares were properly tendered and not properly withdrawn. In accordance with the terms and conditions of the tender offer, and based on the final results reported by the Depositary, the Company has accepted for purchase 16,554,256 shares through the tender offer at a price of $2.00 per share, for an aggregate cost of approximately $33.1 million, excluding fees relating to the tender offer. The number of shares that the Company has accepted for purchase in the tender offer represents approximately 8.4% of the total number of issued ordinary shares of the Company outstanding as of the commencement of the tender offer on December 19, 2023.

08:16 EST State Street sees FY24 NII approximately (10)% year-over-year - Expect 5th consecutive year of business growth-focused investments fully or partially offset by productivity and expense transformation. Planned acceleration of investments supporting Alpha, Private Markets and International Custody business to deliver higher new business sales growth. Expects global equity markets flat to December 2023 EOP which translates to average global equity markets up ~10% YoY. Sees FY24 fee revenue to increase about 3-4% year-over-year. Growth in servicing and management fees driven by higher market levels and business momentum. Sees FY24 expenses up approximately 2.5% year-over-year.

08:09 EST Adtalem Global Education announces new $300M share repurchase program - Adtalem Global Education announced that its board of directors has authorized a new share repurchase program, which allows Adtalem to repurchase up to $300M of its common stock through Jan. 16, 2027. In connection with this announcement, Adtalem disclosed that it completed its February 2022 board authorized $300M share repurchase program on January 16, representing a significant return for our shareholders. Under the February 2022 board authorized $300M repurchase program and prior $163M accelerated share repurchase, or ASR, program agreement, which concluded on October 14, 2022, Adtalem has repurchased 11.6M shares at an average price of $39.85 which represents a reduction in shares outstanding of 23% against base shares outstanding as of February 1, 2022. The company has approximately 39.3M shares of common stock outstanding as of Jan. 16, 2024.

08:04 EST Mangoceuticals' MangoRx brand, products to be featured by Barstool Sports - Mangoceuticals announces that it will be a Marquee Sponsor for Barstool Sports' week-long programming schedule surrounding the Big Game in Las Vegas on Sunday, Feb 11, 2024. The MangoRx brand will be featured across Barstool programming during the week of the Super Bowl, including The Dozen Trivia Live Show Pro-Am with Dave Portnoy and other Barstool fan favorites, Stool Scenes' "Super Bowl Special", and The Rundown, in addition to sponsoring the Big Game's Day-of livestream from Chicago HQ, the brand's content house in Las Vegas, and several other podcasts and radio shows. "The Barstool livestream for the Big Game saw its audience grow by nearly 200% year-over-year from 2022 to 2023," remarked Jacob Cohen, CEO and Co-Founder of MangoRx. "This is dead center in terms of our target market for our major products, and we couldn't find a bigger megaphone to power our brand reach than Dave's empire of influence. Barstool is #1 across the board and we are thrilled to align our brand with Dave and his team for the biggest media event of the year!"

08:03 EST Bionano Genomics announces final speaker lineup for 2024 Symposium - Bionano Genomics announced its 2024 Symposium lineup of 33 oral presentations delivered by 26 different customers worldwide featuring the utility of optical genome mapping across a wide range of research applications in cancer, cell and gene therapy, and genetic disease. 2024 Symposium will take place virtually from January 22 to 25, 2024. During these four days, customers will showcase their latest research findings using OGM. Each day will feature user presentations, a live panel with Q&A, and scientific posters within the virtual exhibition hall. On day 2, Bionano will unveil a new product expected to advance cytogenetics and structural variant analysis.

07:46 EST Processa expands NGC-Cap program into advanced or metastatic breast cancer - Processa Pharmaceuticals plans to expand the development of Next Generation Capecitabine into the treatment of advanced or metastatic breast cancer beginning with its next Phase 2 trial. Following the Processa meeting with the FDA, Processa has decided the next NGC-Cap trial would be a Phase 2 trial in breast cancer. This decision was supported through discussions with the FDA where Processa agreed with the FDA that pursuing breast cancer will lead to a more efficient development program while providing a greater likelihood of FDA approval. The FDA stated that the previously generated data in past and existing studies could be used to directly support the Phase 2 trial in breast cancer.

07:42 EST Ford cuts F-150 Lightning production, sees less than anticipated 2024 EV growth - Ford Motor Company announced plans to create nearly 900 new jobs as part of a new third crew at Michigan Assembly Plant in Wayne to meet demand for the popular Bronco and Bronco Raptor and the all-new Ranger and Ranger Raptor. In addition to nearly 900 net new hires, the new 1,600-person third crew at Michigan Assembly Plant will also include approximately 700 employees from Ford's Rouge Complex in Dearborn who applied for job openings. Ford is adding the manpower this summer to support planned future volume increases for vehicle lines assembled at the plant. The all-new Ranger and Ranger Raptor are on track to launch this year. Michigan Assembly Plant will transition to producing vehicles seven days a week versus five currently, with three crews working two shifts. The company also has capacity available to scale production of gas-powered and hybrid F-150 trucks based on customer demand. Approximately 1,400 employees will be impacted as the Rouge Electric Vehicle Center transitions to one shift effective April 1. Roughly 700 will transfer to Michigan Assembly Plant and the others will be placed in roles at the Rouge Complex or other facilities in Southeast Michigan, or take advantage of the Special Retirement Incentive Program agreed to in the 2023 Ford-UAW contract. A few dozen employees could be impacted at component plants supporting F-150 Lightning production, depending on the number of employees who apply for the Special Retirement Incentive Program. Ford would provide placements for impacted employees within Southeast Michigan. "We are taking advantage of our manufacturing flexibility to offer customers choices while balancing our growth and profitability. Customers love the F-150 Lightning, America's best-selling EV pickup. We see a bright future for electric vehicles for specific consumers, especially with our upcoming digitally advanced EVs and access to Tesla's charging network beginning this quarter," said Ford President and CEO Jim Farley. Reference Link

07:31 EST Venus Concept announces issuance of $2M of convertible notes - Venus Concept issued new secured convertible notes to EW Healthcare Partners, L.P. and one of its affiliates in an aggregate principal amount of $2.0 million. The convertible notes have a maturity date of December 9, 2025 and an annual interest rate of 90-day Adjusted SOFR + 8.5% that is payable in kind on a quarterly basis. The notes are convertible at any time into shares of common stock of the Company at an initial conversion price of $1.251 per share, subject to adjustment. The convertible notes include a mandatory redemption provision for part or all of the notes upon the Company or Venus Concept USA Inc. receiving payments in connection with employee retention credits, and the occurrence of certain specified events.

07:21 EST Huntington Bancshares provides medium-term financial targets - Targets PPNR growth 6%-9%; ROTCE 20%+; ROTCE ex-AOCI 17%-19%; positive operating leverage. Operating assumptions: Adjusted CET1 Ratio: 9 - 10%; Net Charge-offs: 25-45 bps through the cycle; Tax Rate: 19%-21%.

07:08 EST Wayfair implementing 13% workforce reduction - Wayfair announced details related to right-sizing its cost structure, following the series of actions originally initiated in August 2022. The company announced a workforce reduction involving approximately 1,650 employees, representing approximately 13% of its global workforce and approximately 19% of its corporate team, in each case as of December 31, 2023. This action is expected to deliver annualized cost savings of more than $280M. Based on this announcement, in a hypothetical flat revenue environment - inclusive of the rebuilt roles - Wayfair now expects to deliver over $600M of Adjusted EBITDA in 2024. Details include approximately $150M of annualized cash compensation savings, net savings figures incorporating the company's plans to rebuild a portion of the headcount over 2024; approximately $80M of annualized equity-based compensation relief associated with the impacted employees; approximately $50M of annualized savings related to a reduction in capitalized technology labor, which is accounted for as a component of the company's capital expenditures line item. As a result of the workforce reduction, Wayfair expects to incur $70M-$80M of costs, consisting primarily of employee severance and benefit costs, most of which are expected to be incurred in Q1.

07:04 EST Peraso regains compliance with Nasdaq minimum bid price rule - Peraso received a letter from The Nasdaq Stock Market notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement. The letter noted that, as of January 17, 2024, the Company evidenced a closing bid price of its common stock in excess of the $1.00 minimum requirement for the last 10 consecutive trading days. Accordingly, the Company has regained compliance with Nasdaq Marketplace Rule 5550(a)(2) and Nasdaq considers the matter closed.

07:03 EST Spirit Airlines says assessing options to refinance 2025 debt maturities - In a regulatory filing, Spirit Airlines disclosed an investor update as of January 19, in which it states: "As of December 31, 2023, Spirit had $1.3B of liquidity, including unrestricted cash and cash equivalents, short-term investment securities and $300M of liquidity under the company's revolving credit facility. During the fourth quarter, the company took several steps to shore up its liquidity to allow it time to make the necessary strategic shifts to enable the company to compete effectively in the current demand backdrop and to return the business to profitability. In November 2023, Spirit modified its Revolving Credit Facility to, among other things, extend the final maturity to September 30, 2025. In December 2023, the company completed sale-leaseback transactions for 20 aircraft, resulting in repayment of approximately $325M of indebtedness on those aircraft and net cash proceeds of $320M. In January 2024, the company completed sale-leaseback transactions for an additional five aircraft, resulting in repayment of approximately $140M of indebtedness on those aircraft and net cash proceeds of $99M. In total, these transactions resulted in net cash proceeds to the company of approximately $419M. Spirit and Pratt & Whitney have been in negotiations regarding fair compensation for the financial damages related to the geared turbo fan neo engine availability issues. Discussions with Pratt have progressed considerably since October, and while no agreement has been reached to date, the company believes the amount of compensation it will receive will be a significant source of liquidity over the next couple of years. The company is also assessing options to refinance its 2025 debt maturities, including the $1.1B of aggregate principal amount of 8.00% Senior Secured Notes."

07:02 EST Kirkland's names Amy Sullivan as CEO, succeeding Ann Joyce - Kirkland's has promoted Amy Sullivan to CEO, effective February 4, and she will also join the company's board of directors. She succeeds interim CEO Ann Joyce, who will remain on the company's board of directors. Sullivan, who has been with the company for more than a decade, was promoted to President and COO in the spring of 2023. As a member of the executive team, she has helped lead the organization through significant strategic repositioning initiatives, including refocusing marketing efforts and aligning product assortments to drive customer demand. Prior to Kirkland's Home, she held senior-level positions for Express, Lands' End, Kohl's and JCPenney.

07:01 EST OTC Markets Group welcomes Salem Media to OTCQX - OTC Markets Group announced Salem Media Group has qualified to trade on the OTCQX Best Market. Salem Media Group, Inc. previously traded on NASDAQ.

06:59 EST Travelers CEO calls Q4 results 'exceptional' - "We are very pleased to report exceptional top- and bottom-line results for the fourth quarter," said Alan Schnitzer, Chairman and CEO. "Core income, earnings per share and return on equity were all record highs for the quarter, driven by both underwriting and investment results. Record underlying underwriting income resulted from net earned premiums of $10 billion, up more than 13% over the prior year quarter, and an underlying combined ratio which improved 5.5 points to a record 85.9%. Each of our business segments contributed to the improvement. We are also pleased to have delivered full year core income of $3.1 billion, generating core ROE of 11.5%, notwithstanding elevated industry-wide catastrophe losses and an operating environment for our Personal Insurance business that, while improving, was difficult during the year. Our high-quality investment portfolio generated after-tax net investment income of $2.4 billion for the year, driven by strong and reliable returns from our growing fixed income portfolio. Our operating results, together with our strong balance sheet, enabled us to grow adjusted book value per share by 8% during the year to $122.90, after returning nearly $2 billion of excess capital to shareholders through dividends and share repurchases and making important investments in our business. Through excellent marketplace execution across all three segments, we grew net written premiums in the quarter by $1.2 billion, or 13%, to $10 billion. In Business Insurance, we grew net written premiums by 14% to more than $5 billion. Renewal premium change in the segment was very strong at 11.8%, while retention remained historically high at 87% and new business increased significantly. In Bond & Specialty Insurance, we grew net written premiums by 7% to $989 million, achieved 90% retention of our high-quality management liability business and grew net written premiums by 9% in our industry-leading surety business. Given the attractive returns, we are very pleased with the strong production results in both of our commercial business segments. In Personal Insurance, 13% top-line growth was driven by higher pricing. Renewal premium change was 21.2% in our Homeowners and Other business and was 16.7% in our Auto business. Looking ahead, the fundamentals across our business are in excellent shape. In Business Insurance, we are growing while achieving very strong margins. Our Bond & Specialty business continues to produce excellent returns, and we added to our expert cyber capabilities with the strategic acquisition of Corvus. Our Personal Insurance business is showing significantly improved profitability, and the outlook is for continued improvement. Record cash flows have enabled us to make important strategic investments in our business, return excess capital to shareholders and grow our investment portfolio to nearly $93 billion. Combined with higher fixed income yields, this sets us up for higher levels of net investment income moving forward. With another year of very strong results in the books, continued strategic investment in pursuit of our focused innovation agenda and the best talent in the industry, we could not feel more confident about how we are positioned for 2024 and beyond."

06:56 EST SLB plans to increase share repurchases in 2024 - "With confidence in the strength and longevity of the cycle and visibility into sustained strong cash flows, we are pleased to announce that our Board of Directors has approved a 10% increase to our quarterly dividend. Additionally, we plan to increase share repurchases in 2024, visibly enhancing returns to shareholders for the full year."

06:52 EST SLB raises quarterly dividend 10% to 27.5c per share - On January 18, SLB's Board of Directors approved a 10% increase in SLB's quarterly cash dividend from 25c per share of outstanding common stock to 27.5c per share, beginning with the dividend payable on April 4 to stockholders of record on February 7.

06:35 EST Liquidia appoints CFO Michael Kaseta as COO - Liquidia announced updates and promotions to its operations leadership in advance of the potential approval and launch of Yutrepia - treprostinil - inhalation powder. Michael Kaseta, CFO, has added the role of Chief Operating Officer - COO - to his responsibilities effective on January 15, 2023. In connection with this change, Michael Hunter was also promoted to Senior VP of Manufacturing Operations, where he will manage all day-to-day manufacturing and supply chain operations internally and externally. Simultaneously, former COO Robert Lippe will transition out of the Company over a three-month period.

06:32 EST Fisker issues statement on NHTSA preliminary evaluation of braking issues - Fisker has issued a statement on the National Highway Traffic Safety Administration - NHTSA - Office of Defects Investigation's Preliminary Evaluation of reported braking issues with the 2023 Fisker Ocean: "Fisker is fully cooperating with NHTSA on this matter." The Fisker Ocean brake system uses both friction braking and regenerative braking. In December 2023, Fisker responded to customer feedback and issued an Over-the-Air update to the regenerative system that improved the customer experience when traveling over bumps and uneven surfaces, resolving the issue.

06:20 EST The9 CEO to purchase up to 10% of ADSs in open market - The9 announced that it was informed by its chairman and CEO, Jun Zhu, of his intention to use personal funds to purchase up to 10% of the company's outstanding American depositary shares in the open market from time to time at prevailing market prices in accordance with applicable rules and regulations.

06:04 EST Advanced Drainage and Rainwater Management Solutions enter strategic partnership - Advanced Drainage and Rainwater Management Solutions - RMS -, a provider of water harvesting and reuse systems, have initiated a strategic relationship. This collaboration will drive further advancement of sustainable stormwater solutions throughout the U.S. and Canada. By combining ADS' expertise in managing the entire lifecycle of a raindrop and RMS' innovative water harvesting solutions, their combined knowledge and product lines aims to enable the delivery of end-to-end stormwater treatment system solutions for commercial and residential customers. Both ADS and RMS will leverage each other's products when designing right-fit, specialized solutions for customers across commercial, residential, agricultural and infrastructure markets.

05:20 EST DexCom breaks ground on new manufacturing facility in Ireland - DexCom has officially broken ground on its new manufacturing facility, located in Athenry, Co. Galway. This marks the first step in the realization of this facility, which will bring more than 1,000 jobs to the area and represents one of the biggest single private sector investments ever in the West of Ireland. Dexcom's first manufacturing facility in Europe will ensure the flow of products throughout EMEA, with the potential to lower the cost of goods and improve sustainability by decreasing delivery time in transit. The new facility will have the capacity to produce millions of Dexcom rtCGM sensors each year, helping to improve the lives of people with diabetes in EMEA. Dexcom is also further demonstrating its long-term commitment to Europe, and specifically the West of Ireland by announcing a 12-year naming-rights partnership with Connacht Rugby. From today, 'The Sportsground' will be known as 'Dexcom Stadium,' which has been the home of Connacht Rugby since 1927. For information about Dexcom job openings in Athenry go to: careers.dexcom.com/careers.